Effects of tamoxifen and NaF on serum and hepatic enzymes

Fluoride

Volumn 36, Issue 3, 2003, Pages 170-176

  Czerny, Bogusław ^a   Juzyszyn, Zygmunt ^b   Myśliwiec, Zofia ^b   Put, Anna ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b NONE

Author keywords

Cytochrome P 450; Food borne fluoride; Rat intoxication; Serum enzymes; Tamoxifen

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450; FLUORIDE SODIUM; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; TAMOXIFEN CITRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC TOXICITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEAVY METAL POISONING; LIVER FUNCTION; LIVER TOXICITY; MALE; NONHUMAN; RAT; WEIGHT GAIN;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0043192660     PISSN: 00154725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Carthew PC, Edwards RE, Nolan BM, Martin EA, Smith LL. Tamoxifen associated uterine pathology in rodents: relevance to women. Carcinogenesis 1996;17:1577-82.
2. Gusberg SB. Tamoxifen for breast cancer associated endometrial cancer. Cancer 1990;65:1463-4.
3. Magriples U, Naftolin F, Schwartz P, Carcangiu M. High-grade endometrial carcinoma in tamoxifen treated breast cancer patients. J Clin Oncol 1993; 11:485-90.
4. Willen R, Willen H, Lindahe B. Similarity of uterine mucosa changes in patient streated by raloxifen and tamoxifen. Anticancer Res 2002;22(2B):1121-5.
5. Blank RD, Bockman RS. A review of clinical trials of therapies for osteoporosis using fracture as an end point. J Clin Densitom 1999;2(4):435-52.
6. Kleerekoper M. The role of fluoride in the prevention of osteoporosis. Endocrinol Metab Cin North Am 1998;27(2):441-52.
7. Balena R, Kleerekoper M, Foldes IA, Shih MS, Rao DS, Schober HC, Parfitt AM. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone. Osteoporos Int 1998;8(5):428-35.
8. Zilva JF, Pannall PR, editors. Clinical chemistry in diagnosis and treatment. London: A Lloyd-Luke Publication; 1979.
9. Tietz N, editor. Fundamentals of clinical chemistry. Philadelphia: W.B. Saunders; 1986.
10. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties. J Biol Chem 1964;239:2379-85.
11. Williams GH, Kamin M. Microsomal triphosphopyridine nucleotide cytochrome c reduktase of liver. J Biol Chem 1962;237:587-95.
12. Gumińska M. Biochemical mechanism of influence of fluorine on the living organism. Folia Med Cracov 1981;23:305-21.
13. th Symposium on the Metabolism of Fluorine; 1994 Sept. 15, Szczecin, Poland. Szczecin: Polskie Towarzystwo Biochemiczne & Szczecińskie Towarzystwo naukowe; 1994. p 9-11.
14. Singh M, Kanwar KS. Effect of fluoride on tissue enzyme activities in rat. Biochemical and histochemical studies. Fluoride 1981;14:132-41.
15. Machoy Z. Wpływ zwia̧ków fluoru na łańcuch oddechowy [The influence of fluorine compounds on the respiratory chain]. In: Machoy Z, editor. Metabolism of Fluorine. Warsaw, Poznań: PWN; 1982. p 3-5.
16. Kessabi M, Hamliri A, Braun JP, Rico AG. Experimental acute sodium fluoride poisoning in sheep: renal, hepatic and metabolic effects. Fundam Appl Toxicol 1989;5(6 PtI):1025-33.
17. Put A, Myśliwiec A. Die Wirkung von Pollenextracten auf Experimenten mit Ammonium Fluoride hervorgerufene Lebeverandenmgen bei Ratten [The action of pollen extracts in experimental changes induced in rat liver by ammonium fluoride]. Arztezeitschrift für Naturheilverfahren 1993;34:680-6.
18. Juzyszyn A, Put A, Myśliwec Z, Ceglecka M, Ogoński T, Gałka G. Influence of standardized pollen extracts (Cemitin) on the respiratory activity of some tissues of rats subchronically exposed to ammonium fluoride. Phytomedicine 1997;4(4):315-7.
19. Czerny B, Put A, Myśliwiec M, Juzyszyn Z. The influence of quercetin on some parameters of lipid metabolism in rats chronically exposed to ammonium fluoride. Fluoride 2000;33:27-32.
20. Czerny B, Put A, Myśliec Z, Juzyszyn Z. The influence of quercetin on some biochemical parameters in rats exposed to environmental contamination with fluorine compounds. Polish Journal of Environmental Studies 2000;9(3):157-61.
21. Juzyszyn Z, Czerny B, Myśliwiec Z, Put A. Enhancement of kidney and liver respiratory activity by quercetin sulfonates in rats chronically exposed to ammonium fluoride. Fluoride 2002;35(3):161-7.
22. Myśliwiec Z, Machoy-Mokrzyńska A, Juzyszyn Z, Czemy B, Put A. Effects of selenium on serum lipids and enzyme activities in fluoride-intoxicated rats. Fluoride 2002;35(3):168-75.
23. Gutteridge DH, Stewart GO, Price RL, Price RJ, Rettallack RW. A randomized trial of sodium fluoride (60mg) +/-estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures. Osteoporsis Int 2002;13(2):158-70.
24. Mandlekar S, Hebbar V, Christor K, Kong AN. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines. Cancer Res 2000;60(23):6601-6.
25. Ching CK, Smith PG, Long RL. Tamoxifen associated hepatocellular damage and agranulocytosis. Lancet 1992;339:940-8.
26. De-Matteis F, White IN, Smith LL. Species differences in the metabolic activation of tamoxifen into genotoxic derivatives: risk assessment in women. Eur J Drug Metab Pharmacokinet 1998;23:425-8.
27. White IN. The tamoxifen dilema. Carcinogenesis 1999;20:1153-60.
28. Morello KC, Wurz GT, De Gregorio MW. Serms: current status and future trends. Crit Rev Oncol Hematol 2002;43(1):63-76.